Antidepressant-Induced sexual dysfunction among newer antidepressants in a naturalistic setting

Psychiatry Investigation

Volumn 7, Issue 1, 2010, Pages 55-59

  Lee, Kyoung Uk ^a   Lee, Young Min ^b   Nam, Ji Min ^a   Lee, Hae Kook ^a   Kweon, Yong Sil ^a   Lee, Chung Tai ^a   Jun, Tae Youn ^a  

^a The Catholic University of Korea   (South Korea)

^b Pusan National University School of Medicine   (South Korea)

Author keywords

Antidepressants; Depression; Sexual dysfunction

Indexed keywords

ANTIDEPRESSANT AGENT; CITALOPRAM; FLUOXETINE; MIRTAZAPINE; PAROXETINE; VENLAFAXINE;

ADULT; ARTICLE; CONTROLLED STUDY; DEMOGRAPHY; DEPRESSION; DIAGNOSTIC AND STATISTICAL MANUAL OF MENTAL DISORDERS; DRUG USE; FEMALE; HUMAN; INCIDENCE; MAJOR CLINICAL STUDY; MALE; MEDICAL RECORD; RATING SCALE; SEXUAL DYSFUNCTION; TREATMENT DURATION;

EID: 77950793270     PISSN: 17383684     EISSN: None     Source Type: Journal    
DOI: 10.4306/pi.2010.7.1.55     Document Type: Article

References (28)

1. Waldinger MD, Hengeveld MW, Zwinderman AH, Olivier B. Effect of SSRI antidepressants on ejaculation: a double-blind, randomized, placebo-controlled study with fluoxetine, fluvoxamine, paroxetine, and sertraline. J Clin Psychopharmacol 1998; 18: 274-281.
2. Lane RM. A critical review of selective serotonin reuptake inhibitorrelated sexual dysfunction; incidence, possible aetiology and implications for management J Psychopharmacol 1997; 11: 72-82.
3. Waldinger MD, Olivier B. Selective serotonin reuptake inhibitor-induced sexual dysfunction: clinical and research considerations. Int Clin Psychopharmacol 1998; 13 Suppl 6: S27-S33.
4. Gregorian RS, Golden KA, Bahce A, Goodman C, Kwong WJ, Khan ZM. Antidepressant-induced sexual dysfunction. Ann Pharmacother 2002; 36: 1577-1589.
5. Clayton AH. Female sexual dysfunction related to depression and antidepressant medications. Curr Womens Health Rep 2002; 2: 182-187.
6. Roose SP. Tolerability and patient compliance. J Clin Psychiatry 1999; 60 Suppl 17: 14-7; discussion 46-48.
7. Montejo AI, Llorca G, Izquierdo JA, Ledesma A, Bousoflo M, Calcedo A, et al. Sexual dysfunction secondary to SSRIs. A comparative analysis in 308 patients. Actas Luso Esp Neurol Psiquiatr Cienc Afines 1996; 24: 311-321.
8. Fava M, Rankin M. Sexual functioning and SSRIs. J Clin Psychiatry 2002; 63 Suppl 5: 13-16; discussion 23-25.
9. Kennedy SH, Eisfeld BS, Dickens SE, Bacchiochi JR, Bagby RM. Antidepressant-induced sexual dysfunction during treatment with moclobemide, paroxetine, sertraline, and venlafaxine. J Clin Psychiatry 2000; 61: 276-281.
10. Chae JH, Lee KU, Shin YK, Bahk WM, Jun. TY, Kim KS, et al. Comparison of side effect profiles between mirtazapine and selective serotonin reuptake inhibitors; An naturalistic setting. Clinical Psychopharmacology and Neuroscience 2004; 2: 31-35.
11. McGahuey CA, Gelenberg AJ, Laukes CA, Moreno FA, Delgado PL, McKnight KM, et al. The Arizona Sexual Experience Scale (ASEX) : reliability and validity. J Sex Marital Ther 2000; 26: 25-40.
12. Association AP. Diagnostic and statistical manual of mental disorders, 4th edition, text revision. Washington DC: American Psychiatric Association; 2000.
13. Beck AT, Ward CH, Mendelson M, Mock J, Erbaugh J. An inventory for measuring depression. Arch Gen Psychiatry 1961; 4: 561-571.
14. Spielberger CD. Manual for the state-trait anxiety inventory: a comprehensive bibliography. Palo Alto, CA: Cunsulting Psychologists Press; 1989.
15. Spielberger CD. Manual for the state-trait anxiety inventory. Palo Alto, CA: Consulting Psychologists Press; 1983.
16. Margolese HC, Assalian P. Sexual side effects of antidepressants: a review. J Sex Marital Ther 1996; 22: 209-217. (Pubitemid 26314106)
17. Montejo AL, Llorca G, Izquierdo JA, Rico-Villademoros F. Incidence of sexual dysfunction associated with antidepressant agents: a prospective multicenter study of 1022 outpatients. Spanish Working Group for the Study of Psychotropic-Related Sexual Dysfunction. J Clin Psychiatry 2001; 62 Suppl 3: 10-21.
18. Baldwin DS. Sexual dysfunction associated with antidepressant drugs. Expert Opin Drug Saf 2004; 3: 457-470.
19. Stahl SM. The psychopharmacology of sex, Part 1: Neurotransmitters and the 3 phases of the human sexual response. J Clin Psychiatry 2001; 62: 80-81.
20. Goodnick PJ, Chaudry T, Artadi J, Arcey S. Women's issues in mood disorders. Expert Opin Pharmacother 2000; 1: 903-916.
21. Nadeem HS, Attenburrow MJ, Cowen PJ. Comparison of the effects of citalopram and escitalopram on 5-Ht-mediated neuroendocrine responses. Neuropsychopharmacology 2004; 29: 1699-1703.
22. Boolell M, Allen MJ, Ballard SA, Gepi-Attee S, Muirhead GJ, Naylor AM, et al. Sildenafil: an orally active type 5 cyclic GMP-specific phosphodiesterase inhibitor for the treatment of penile erectile dysfunction. Int J Impot Res 1996; 8: 47-52.
23. Angulo J, Peiró C, Sanchez-Ferrer CF, Gabancho S, Cuevas P, Gupta S, et al. Differential effects of serotonin reuptake inhibitors on erectile responses, NO-production, and neuronal NO synthase expression in rat corpus cavernosum tissue. Br J Pharmacol 2001; 134: 1190-1194.
24. Preskorn SH. Comparison of the tolerability of bupropion, fluoxetine, imipramine, nefazodone, paroxetine, sertraline, and venlafaxine. J Clin Psychiatry 1995; 56 Suppl 6: 12-21.
25. Baldwin DS, Birtwistle J. Antidepressant drugs and sexual function: improving the recognition and management of sexual dysfunction in depressed patients. J Clin Psychiatry 1998; 59 Suppl 8: 39-44.
26. Stahl SM. Basic psychopharmacology of antidepressants, part 1: Antidepressants have seven distinct mechanisms of action. J Clin Psychiatry 1998; 59 Suppl 4: 5-14.
27. Asch DA, Jedrziewski MK, Christakis NA. Response rates to mail surveys published in medical journals. J Clin Epidemiol 1997; 50: 1129-1136.
28. Dunn KM, Croft PR, Hackett GI. Sexual problems: a study of the prevalence and need for health care in the general population. Fam Pract 1998; 15: 519-524.